Concepedia

Author

Inge M. van Oort

Radboud University NijmegenORCID

Also Known As

I M van Oort, I van Oort, I. M. Van Oort, I. M. van Oort, I. Van Oort, I. van Oort, I.M van Oort, I.M. Oort, I.M. Van Oort, I.M. van Oort

425

Publications

12.7K

Citations

52

H-Index

69

Concepts

All Affiliations

Radboud University NijmegenRadboud University Medical CenterCanisius-Wilhelmina ZiekenhuisThe Netherlands Cancer InstituteNetherlands Comprehensive Cancer Organisation
IM

About

Inge M. van Oort is an author at Radboud University Nijmegen specializing in medicine, urology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

30

3.4K

2

Health Sciences

9

9

648

3

Engineering

2

2

64

4

Biostatistics

2

2

387

5

Communication

1

1

43

Inge M. van Oort

×

111

Publications

9.4K

Citations

48

H-Index

YearCitations

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study

Marloes van der Leest, Erik B. Cornel, Bas Israël,

European Urology

2018

740

DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer

Daphne Hessels, Jacqueline M. T. Klein Gunnewiek, Inge M. van Oort,

European Urology

2003

697

Relationship between Apparent Diffusion Coefficients at 3.0-T MR Imaging and Gleason Grade in Peripheral Zone Prostate Cancer

Thomas Hambrock, Diederik M. Somford, Henkjan Huisman,

Radiology

2011

560

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

Silke Gillessen, Gerhardt Attard, Tomasz M. Beer,

European Urology

2020

384

Magnetic Resonance Imaging Guided Prostate Biopsy in Men With Repeat Negative Biopsies and Increased Prostate Specific Antigen

Thomas Hambrock, Diederik M. Somford, Caroline Hoeks,

The Journal of Urology

2009

363

Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score

Leander Van Neste, Rianne J. Hendriks, Siebren Dijkstra,

European Urology

2016

359

Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer

G.H.J.M. Leyten, Daphne Hessels, Sander A. Jannink,

European Urology

2012

354

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility

Patrick Sulem, Daníel F. Guðbjartsson, Thórarinn Blöndal,

Nature Genetics

2009

351

Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort

Thomas Hambrock, Caroline Hoeks, Christina Hulsbergen‐van de Kaa,

European Urology

2011

305

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial

Johann S. de Bono, Niven Mehra, Giorgio V. Scagliotti,

The Lancet Oncology

2021

269

Page 1